Table 3 Association between enhanced hemodynamic fluctuation (≥30%) and selected clinical factors

Age (year)

1.01 (1.01–1.02)

< 0.001

–

Female sex

1.04 (0.85–1.27)

0.73

–

ASA-PS scale, 3 or 4 vs. 1 or 2

1.10 (0.82–1.49)

0.53

0.87 (0.62–1.24)

0.45

Anesthesia start time, P.M. vs. A.M.

1.16 (0.94–1.43)

0.17

1.14 (0.92–1.41)

0.22

Ischemic heart disease

1.76 (1.14–2.71)

0.01

1.51 (0.93–2.46)

0.10

Peripheral vascular disease

1.76 (0.89–3.47)

0.11

1.39 (0.67–2.88)

0.38

Aortic aneurysm

2.25 (0.80–6.34)

0.14

1.55 (0.51–4.70)

0.44

Stroke

1.42 (0.95–2.14)

0.10

1.23 (0.77–1.95)

0.38

Diabetes mellitus

1.29 (0.99–1.67)

0.06

1.12 (0.85–1.48)

0.41

Hyperlipidemia

1.22 (0.95–1.56)

0.12

1.03 (0.79–1.35)

0.82

Hypoalbminemia

1.27 (0.95–1.71)

0.12

1.17 (0.85–1.61)

0.34

Antithrombotic drug use

1.23 (0.91–1.67)

0.18

0.91 (0.63–1.32)

0.62

Propofol (mg/kg)

0.71 (0.59–0.87)

< 0.001

0.81 (0.65–1.01)

0.06

Fentanyl (μg/kg)

0.80 (0.66–0.96)

0.02

0.84 (0.69–1.02)

0.08

Midazolam (mg)

0.75 (0.47–1.20)

0.18

0.79 (0.49–1.27)

0.33